Marketing-authorisation holder
Nutrimedika U.S.A.
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Q-GEL COENZYME Q1015 mg / cap · Capsule | Ubidecarenone | Canada | Cancelled | 1999 |
| Q-GEL FORTE COENZYME Q1030 mg / cap · Capsule | Ubidecarenone | Canada | Cancelled | 1999 |
| THERA Q PLUS30 mg / cap + 100 unit / cap · Capsule | Ubidecarenone, Vitamin e | Canada | Cancelled | 1999 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 3 | 0 | 3 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Cardiac therapyCardiovascular system · ATC C01E
- VitaminsAlimentary tract and metabolism · ATC A11J
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- nutrimedika u
- nutrimedika u s a
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder